Skibsted Russell
SEC-identified person · CIK 1308105 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Processa Pharmaceuticals, Inc. PCSA | Chief Financial Officer | filed 2024–2026 |
| Alimera Sciences INC ALM | Chief Financial Officer & SVP | filed 2023–2023 |
| Rockwell Medical, INC. rmti | See Remarks | filed 2020–2022 |
| Serina Therapeutics, Inc. SER | Chief Financial Officer | filed 2018–2019 |
| Lineage Cell Therapeutics, Inc. LCTX | Chief Financial Officer | filed 2015–2018 |
| Oncocyte Corp OCX | Chief Financial Officer | filed 2015–2015 |
| Sunpeaks Ventures, INC. SNPK | Former Executive Vice Pres. | filed 2014–2014 |
| Aeolus Pharmaceuticals, INC. AOLS.OB | Chief Financial Officer | filed 2011–2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.